Immunovant, Inc., a clinical-stage immunology company dedicated to enabling normal lives for people with autoimmune diseases, announced that Pete Salzmann, M.D., chief executive officer, will participate in fireside chats at the following investor conferences.
November 13, 2023
· 1 min read